Instituto do Cancer do Estado de São Paulo   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Sao Paulo Brazil (2008)

Organization Overview

First Clinical Trial
2010
NCT02508857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fauze Maluf Filho | ICESP - HCFMUSP | Instituto do Cancer do Estado de Sao Paulo | Instituto do Cancer do Estado de São Paulo | Instituto do Câncer do Estado de São Paulo | Instituto do Câncer do Estado de São Paulo | Tiago Biachi